| Literature DB >> 34415938 |
Marieke K Jones1,2, Thomas B Huff3, Elizabeth W Freeman1,4, Nucharin Songsasen1.
Abstract
The maned wolf (Chrysocyon brachyurus) is an induced ovulator. Though the mechanism of ovulation induction remains unknown, it is suspected to be urinary chemical signals excreted by males. This study assessed volatile organic compounds (VOCs) in weekly urine samples across 5 months from 13 maned wolves (6 intact males, 1 neutered male, 6 females) with the goal of identifying VOCs that are differentially expressed across sex, reproductive status, and pairing status. Solid-phase microextraction (SPME) and gas chromatography-mass spectrometry (GC-MS) were used to extract and separate VOCs that were identified via spectral matching with authentic standards, with spectral libraries, or with new software that further matches molecular fragment structures with mass spectral peaks. Two VOCs were present across all 317 urine samples: 2,5-dimethyl pyrazine and 2-methyl-6-(1-propenyl)-pyrazine. Fifteen VOCs differed significantly (Adj. P < 0.001 and |log2 fold change| >2.0) between intact males and females. Using partial least squares-discriminant analysis, the compounds with the highest importance to the sex classification were delta-decalactone, delta-dodecalactone, and bis(prenyl) sulfide. Sixty-two VOCs differed between intact males and the neutered male. Important classifier compounds were 3-ethyl 2,5-dimethyl pyrazine, 2-methyl-6-(1-propenyl)-pyrazine, and tetrahydro-2-isopentyl-5-propyl furan. Several VOCs established as important here have been implicated in reproductive communication in other mammals. This study is the most robust examination of differential expression in the maned wolf thus far and provides the most comprehensive analysis of maned wolf urinary VOCs to date, increasing the sample size substantially over previous chemical communication studies in this species. New data analysis software allowed for the identification of compounds in the hormone-producing mevalonate pathway which were previously unreported in maned wolf urine. Several putative semiochemicals were identified as good candidates for behavioral bioassays to determine their role in maned wolf reproduction, and specifically in ovulation induction.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34415938 PMCID: PMC8378691 DOI: 10.1371/journal.pone.0256388
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic information for maned wolves that supplied urine samples.
| SB# | Age | Sex | Institution | Housed with | Pairing Status | Breeding Information |
|---|---|---|---|---|---|---|
| 3231 | 3 | F | Beardsley | SB#3232 (same sex sibling) | Unpaired | N/A |
| 3232 | 3 | F | Beardsley | SB#3231 (same sex sibling) | Unpaired | N/A |
| 2845 | 8 | F | Fossil Rim |
| Unpaired | None seen |
| 3192 | 3 | M | Philadelphia | SB#3195 (same sex sibling) | Unpaired | N/A |
| 3195 | 3 | M | Philadelphia | SB#3192 (same sex sibling) | Unpaired | N/A |
| 2810 | 8 | M | SCBI | Single | Unpaired | N/A |
| 3206 | 4 | M | Fossil Rim | SB#3207 (spayed sister) | Unpaired | N/A |
| 2844 | 8 | M | SCBI | SB#3184 | Paired | None seen |
| 3184 | 4 | F | SCBI | SB#2844 | Paired | None seen |
| 2660 | 10 | M | WOCC | SB#2945 | Paired | Estimated breeding date Oct 8, 2014 |
| 2945 | 8 | F | WOCC | SB#2660 | Paired | Estimated breeding date Oct 8, 2014 |
| 2536 | 11 | F | Buffalo | SB#3014 (neutered male) | N/A | N/A |
| 3014 | 7 | NeutM | Buffalo | SB#2536 (11 yr old female) | N/A | N/A |
aStudbook Number. Association of Zoos and Aquarium reference number of individual pedigree and demographic history.
bInstitution
Beardsley: Beardsley Zoo, Bridgeport, CT; Buffalo: Buffalo Zoo, Buffalo, NY; Fossil Rim: Fossil Rim Wildlife Center, Glen Rose, TX; Philadelphia: Philadelphia Zoo, Philadelphia, PA; SCBI: Smithsonian Conservation Biology Institute, Front Royal, VA; WOCC: White Oak Conservation Center, Yulee, FL
cHoused with: Details on the housing situation for each individual.
*SB#2845 was housed with SB#3006 (male) and her 3 yearling pups from Aug 1—Sept 9, 2014 then with her 3 yearling pups from Sept 10—Dec 31, 2014.
$Urine samples could not be individually attributed between this pair of brothers.
dPairing Status: Unpaired: not housed with a reproductive mate; Paired: housed with a reproductive mate; N/A: excluded from analysis of paired v. unpaired individuals because female was past prime reproductive age and male was neutered.
eBreeding Information: Details on breeding are included here. N/A is used in cases where there was no opportunity for breeding to occur due to pairing status.
VOC found in high abundance and with high frequency across maned wolf urine samples.
| Compound | RT | CAS No. | Identification Methodb | Raw Abundance | % Samples where Present | |
|---|---|---|---|---|---|---|
| Mean | SD | |||||
|
| ||||||
| 2,5-dimethyl pyrazine | 9.29 | 123-32-0 | S | 44104661 | 19238004 | 100.0 |
| 2-methyl-6-(1-propenyl)-pyrazine | 13.57 | 18217-81-7 | NIST17 | 32153093 | 19321932 | 100.0 |
| 2-ethenyl-6-methyl-pyrazine | 12.47 | 13925-09-2 | S | 8608044 | 9157320 | 100.0 |
| 3-ethyl 2,5-dimethyl pyrazine | 11.57 | 13360-65-1 | NIST17 | 5844753 | 6781037 | 100.0 |
| methyl prenyl sulfide | 7.00 | 5897-45-0 | NIST17 / MSI | 5712228 | 13049045 | 100.0 |
| geranyl nitrile | 21.36 | 5146-66-7 | NIST17 | 5514777 | 14339874 | 90.8 |
| prenol | 9.25 | 556-82-1 | S | 3453591 | 2669099 | 100.0 |
| (Z)-2-penten-2-ol | 4.39 | 61923-54-4 | NIST17 / MSI | 3445526 | 2208430 | 75.9 |
| prenyl bromide | 12.48 | 870-63-3 | NIST17 | 2982101 | 9064296 | 99.3 |
| 2-isopropyl-5-methylpyrazine | 10.74 | 13925-05-8 | NIST17 | 1821186 | 1676289 | 87.9 |
|
| ||||||
| 2,5-dimethyl pyrazine | 9.29 | 123-32-0 | S | 43198752 | 19896212 | 100.0 |
| 2-methyl-6-(1-propenyl)-pyrazine | 13.57 | 18217-81-7 | NIST17 | 15685846 | 14255934 | 100.0 |
| 3-ethyl 2,5-dimethyl pyrazine | 11.57 | 13360-65-1 | NIST17 | 2882259 | 2472631 | 96.9 |
| 4-heptanone | 5.88 | 123-19-3 | S | 2545357 | 1949697 | 96.3 |
| (Z)-2-penten-2-ol | 4.39 | 61923-54-4 | NIST17 / MSI | 2406959 | 1620815 | 73.3 |
| prenol | 9.25 | 556-82-1 | S | 1769883 | 1673904 | 98.8 |
| 2-ethenyl-6-methyl-pyrazine | 12.47 | 13925-09-2 | S | 1590649 | 2690336 | 95.7 |
| 2-isopropyl-5-methylpyrazine | 10.74 | 13925-05-8 | NIST17 | 1414256 | 1190236 | 91.9 |
| methyl prenyl sulfide | 7.00 | 5897-45-0 | NIST17 / MSI | 941837 | 1840391 | 98.8 |
| trimethyl-pyrazine | 10.99 | 14667-55-1 | NIST17 | 815179 | 2095624 | 71.4 |
|
| ||||||
| 2,5-dimethyl pyrazine | 9.29 | 123-32-0 | S | 1808665 | 2061746 | 100.0 |
| 4-heptanone | 5.88 | 123-19-3 | S | 540474 | 455294 | 100.0 |
| 2-ethenyl-6-methyl-pyrazine | 12.47 | 13925-09-2 | S | 454826 | 533752 | 100.0 |
| 2-ethyl-1-hexanol | 12.40 | 104-76-7 | NIST17 / MSI | 310368 | 393021 | 93.3 |
| acetophenone | 15.97 | 98-86-2 | S | 288733 | 723863 | 100.0 |
| 2-isopropyl-5-methylpyrazine | 10.74 | 13925-05-8 | NIST17 | 274991 | 448499 | 86.7 |
| N-acetylpyrrole | 13.68 | 609-41-6 | NIST17 / MSI | 164406 | 84832 | 100.0 |
| 4-butoxy-2-butanone | 8.95 | 30536-44-8 | NIST17 / MSI | 163595 | 135777 | 86.7 |
| benzaldehyde | 13.27 | 100-52-7 | S | 161798 | 206243 | 100.0 |
| 3-ethylcyclopentanone | 9.50 | 10264-55-8 | S | 122202 | 89567 | 93.3 |
aIdentification method
S = Experimental spectrum matched to authentic standard.
N17 = Experimental spectrum matched to NIST17 spectral library.
MSI = Experimental spectrum ion fragments matched to structure fragments in NIST MS Interpreter.
VOCs that differed significantly between male and female maned wolf urine samples.
| Compound | RT | CAS No. | Identification Method | Normalized Abundance mean ± SD | Log2 Fold Change | Variable Importance on Projection | ||
|---|---|---|---|---|---|---|---|---|
| Male N = 6 wolves N = 141 samples | Female N = 6 wolves N = 161 samples | |||||||
| delta-decalactone | 28.61 | 705-86-2 | NIST17 / MSI | 1.66 ± 1.27 | -1.45 ± 1.15 | 4.60 | 4.33E-64 | 3.00 |
| delta-dodecalactone | 29.25 | 713-95-1 | NIST17 / MSI | 1.37 ± 1.39 | -1.20 ± 0.62 | 4.01 | 9.48E-60 | 2.47 |
| bis(prenyl) sulfide | 14.47 | Pubchem# 11095069 | MSI | 1.23 ± 1.33 | -1.08 ± 1.49 | 4.44 | 1.00E-33 | 2.22 |
| prenyl bromide | 12.67 | 870-63-3 | NIST17 / MSI | 1.19 ± 1.30 | -1.04 ± 1.35 | 5.74 | 1.55E-35 | 2.15 |
| isoprenyl alcohol | 3.86 | 115-18-4 | S | 1.16 ± 1.79 | -1.01 ± 1.64 | 2.60 | 4.64E-31 | 2.13 |
| geranyl nitrile | 21.35 | 5146-66-7 | NIST17 | 1.18 ± 1.58 | -1.03 ± 1.30 | 6.09 | 7.39E-23 | 2.09 |
| 3-butyl-2,5-dimethyl-pyrazine | 15.01 | 40790-29-2 | NIST17 | 1.08 ± 1.56 | -0.94 ± 1.57 | 2.46 | 1.94E-23 | 1.95 |
| gamma-diosphenol | 13.54 | 54783-36-7 | NIST17 / MSI | 0.93 ± 1.44 | -0.82 ± 0.62 | 3.04 | 2.62E-33 | 1.68 |
| N-acetylpyrrole | 13.68 | 609-41-6 | NIST17 / MSI | -0.87 ± 1.63 | 0.76 ± 1.53 | -2.34 | 2.04E-16 | 1.57 |
| 2-ethenyl-6-methyl-pyrazine | 12.47 | 13925-09-2 | S | 0.80 ± 1.55 | -0.70 ± 1.56 | 2.26 | 1.65E-14 | 1.44 |
| prenylthiol | 27.36 | 5287-45-6 | NIST17 | 0.79 ± 1.94 | -0.69 ± 1.76 | 2.39 | 7.67E-11 | 1.43 |
| 3-hepten-2-one | 8.91 | 1119-44-4 | S | -0.78 ± 1.06 | 0.69 ± 1.66 | -2.30 | 1.32E-16 | 1.42 |
| 2,4,6,7-tetramethylbenzofuran | 21.80 | Pubchem# 101630179 | NIST17 | 0.68 ± 1.60 | -0.59 ± 0.77 | 2.56 | 2.04E-16 | 1.22 |
| isoprenyl methyl sulfide | 19.18 | 5952-75-0 | NIST17 / MSI | 0.58 ± 1.87 | -0.51 ± 1.69 | 3.01 | 7.45E-07 | 1.05 |
| 2,4-di-tert-butylphenol | 29.55 | 96-76-4 | NIST17 | -0.46 ± 1.18 | 0.40 ± 1.60 | -2.32 | 1.05E-06 | 0.82 |
aCompounds listed are those that met significance criteria of Adj. P < 0.001 and |log2 fold change| > 2.0.
bIdentification method
S = Experimental spectrum matched to authentic standard.
N17 = Experimental spectrum matched to NIST17 spectral library.
MSI = Experimental spectrum ion fragments matched to structure fragments in NIST MS Interpreter.
Fig 1Classification of male and female urine samples based on abundance of 76 VOC.
(a) Scores on first 2 latent variables from partial least squares-discriminant analysis shown for female samples (n = 161) in gray circles and male samples (n = 141) in black triangles. Variance explained by each latent variable is shown in parentheses. (b) Variable influence on projection (VIP) scores on partial least squares latent variable 1 shown for 15 VOCs with statistically significant differential expression. Boxes on right indicate the log2 fold change in abundance of each VOC in male samples (n = 141) compared to female samples (n = 161).
VOCs that differed significantly between intact and neutered male maned wolf urine samples.
| Compound | RT | CAS No. | Identification Method | Normalized Abundance mean ± SD | Log2 Fold Change | Variable Importance on Projection | ||
|---|---|---|---|---|---|---|---|---|
| Intact Male N = 6 wolves N = 141 samples | Neutered Male N = 1 wolf N = 15 samples | |||||||
| 3-ethyl 2,5-dimethyl pyrazine | 11.57 | 13360-65-1 | NIST17 | 0.46 ± 0.94 | -4.31 ± 1.80 | 6.84 | 3.46E-35 | 2.09 |
| 2-methyl-6-(1-propenyl)-pyrazine | 13.57 | 18217-81-7 | NIST17 | 0.45 ± 0.77 | -4.20 ± 1.05 | 6.96 | 3.90E-46 | 2.04 |
| tetrahydro-2-isopentyl-5-propyl furan | 23.16 | 33933-71-0 | NIST17 | 0.43 ± 0.91 | -4.04 ± 0.94 | 6.96 | 3.59E-38 | 1.96 |
| prenol | 9.25 | 556-82-1 | S | 0.41 ± 0.71 | -3.87 ± 2.21 | 3.85 | 7.48E-35 | 1.88 |
| prenyl bromide | 12.48 | 870-63-3 | NIST17 | 0.41 ± 1.27 | -3.85 ± 0.94 | 10.14 | 1.79E-24 | 1.87 |
| isoprenyl methyl sulfide | 19.09 | 5952-75-0 | NIST17 | 0.41 ± 0.95 | -3.85 ± 0.96 | 6.27 | 2.05E-34 | 1.87 |
| 3,5-dimethyl-2-propyl pyrazine | 12.97 | 32350-16-6 | NIST17 | 0.40 ± 1.19 | -3.77 ± 0.99 | 7.15 | 8.50E-26 | 1.83 |
| ±-β,β-dimethyl-γ-(hydroxy-methyl)-γ-butyrolactone | 19.36 | 52398-48-8 | NIST17 | 0.39 ± 0.83 | -3.62 ± 1.04 | 5.50 | 1.79E-36 | 1.76 |
| 4-butoxy-2-butanone | 8.95 | 30536-44-8 | NIST17 / MSI | -0.38 ± 1.00 | 3.57 ± 1.52 | -4.65 | 1.92E-27 | 1.73 |
| bis(prenyl) sulfide | 14.48 | Pubchem# 11095069 | MSI | 0.37 ± 1.38 | -3.47 ± 0.86 | 7.87 | 5.45E-19 | 1.68 |
| geranyl nitrile | 21.36 | 5146-66-7 | NIST17 | 0.36 ± 1.78 | -3.40 ± 0.74 | 11.52 | 7.07E-13 | 1.65 |
| delta-decalactone | 28.61 | 705-86-2 | NIST17 / MSI | 0.35 ± 1.42 | -3.27 ± 1.26 | 5.33 | 2.59E-16 | 1.59 |
| 2,5-dimethyl pyrazine | 9.29 | 123-32-0 | S | 0.33 ± 0.70 | -3.08 ± 1.85 | 2.81 | 3.02E-29 | 1.49 |
| 1-(3,5-dimethylpyrazinyl)-ethanone | 16.44 | 54300-08-2 | S | 0.32 ± 1.09 | -3.04 ± 1.06 | 4.64 | 3.02E-21 | 1.48 |
| 3-methylbenzaldehyde | 15.91 | 620-23-5 | NIST17 | -0.29 ± 0.79 | 2.74 ± 2.26 | -5.42 | 3.01E-20 | 1.33 |
| N-acetylpyrrole | 13.68 | 609-41-6 | NIST17 / MSI | -0.29 ± 1.62 | 2.72 ± 0.85 | -3.68 | 1.72E-10 | 1.32 |
| 3-acetyl-2,4-dimethylfuran | 14.38 | NA | NIST17 | -0.29 ± 1.18 | 2.71 ± 0.97 | -3.47 | 2.36E-16 | 1.32 |
| prenol | 9.21 | 5287-45-6 | NIST17 / MSI | -0.29 ± 1.40 | 2.70 ± 1.39 | -3.62 | 2.82E-12 | 1.31 |
| 2,5-dimethyl-3-(3-methylbutyl)-pyrazine | 16.05 | 18433-98-2 | NIST17 | 0.29 ± 1.62 | -2.69 ± 0.84 | 5.88 | 2.01E-10 | 1.31 |
| 4-methyl-2-heptanone | 7.36 | 6137-06-0 | NIST17 | -0.29 ± 0.94 | 2.69 ± 2.32 | -4.71 | 8.52E-17 | 1.31 |
| 2-ethyltetrahydrofuran | 16.76 | 1003-30-1 | NIST17 / MSI | -0.29 ± 0.94 | 2.69 ± 1.55 | -3.67 | 6.11E-20 | 1.31 |
| nonanal | 10.64 | 124-19-6 | S | -0.28 ± 1.51 | 2.63 ± 1.20 | -3.68 | 9.04E-11 | 1.27 |
| methyl ester nonanoic acid | 12.56 | 1731-84-6 | S | -0.27 ± 1.24 | 2.58 ± 1.61 | -3.60 | 3.65E-13 | 1.25 |
| 3-butyl-2,5-dimethyl-pyrazine | 15.01 | 40790-29-2 | NIST17 | 0.26 ± 1.65 | -2.47 ± 0.85 | 5.43 | 7.22E-09 | 1.20 |
| tetrahydro-2,5-dimethyl-2H-pyranmethanol | 10.93 | 54004-46-5 | NIST17 | -0.25 ± 1.09 | 2.32 ± 1.73 | -4.07 | 4.62E-13 | 1.13 |
| N,N-dibutyl-formamide | 18.58 | 761-65-9 | S | -0.24 ± 1.03 | 2.25 ± 1.68 | -3.70 | 2.24E-13 | 1.09 |
| diphenylamine | 34.76 | 122-39-4 | S | -0.24 ± 0.94 | 2.22 ± 1.48 | -3.59 | 3.57E-15 | 1.08 |
| prenylthiol | 27.37 | 5287-45-6 | NIST17 | 0.24 ± 1.94 | -2.21 ± 0.80 | 7.11 | 7.14E-06 | 1.07 |
| 2-pentyl furan | 7.70 | 3777-69-3 | NIST17 | -0.24 ± 0.81 | 2.21 ± 1.16 | -2.70 | 3.13E-19 | 1.07 |
| unknown | 30.01 | -0.23 ± 0.93 | 2.21 ± 0.89 | -2.53 | 6.97E-17 | 1.07 | ||
| 2,4-di-tert-butylphenol | 29.56 | 96-76-4 | NIST17 | -0.23 ± 1.23 | 2.18 ± 1.46 | -3.10 | 1.72E-10 | 1.06 |
| isoprenyl alcohol | 3.86 | 115-18-4 | S | 0.23 ± 1.66 | -2.14 ± 0.87 | 4.77 | 4.73E-07 | 1.04 |
| isophorone | 10.85 | 78-59-1 | NIST17 | -0.22 ± 1.16 | 2.06 ± 1.67 | -3.12 | 4.00E-10 | 1.00 |
| 3-hepten-2-one | 8.93 | 1119-44-4 | S | -0.22 ± 1.15 | 2.05 ± 2.06 | -3.76 | 1.60E-09 | 1.00 |
| 5-methyl-5-(1-methylethyl)-3-heptyne-2,6-dione | 11.29 | 63922-44-1 | NIST17 | -0.22 ± 1.00 | 2.05 ± 1.51 | -2.73 | 1.61E-12 | 0.99 |
| 2-methyl, 3-hydroxy-2,4,4-trimethylpentyl ester propanoic acid | 20.67 | 74367-34-3 | NIST17 | -0.22 ± 1.73 | 2.04 ± 1.28 | -1.98 | 4.82E-06 | 0.99 |
| delta-dodecalactone | 29.25 | 713-95-1 | NIST17 / MSI | 0.21 ± 1.48 | -1.99 ± 0.96 | 3.64 | 1.99E-07 | 0.96 |
| trimethyl-pyrazine | 10.99 | 14667-55-1 | NIST17 | 0.20 ± 2.00 | -1.91 ± 0.75 | 6.14 | 1.32E-04 | 0.93 |
| methyl 1-methyl-2-butenyl sulfide | 19.18 | 89534-73-6 | NIST17 | 0.20 ± 1.85 | -1.90 ± 0.80 | 6.71 | 4.51E-05 | 0.92 |
| tert-butyl pivalate | 14.94 | 16474-43-4 | NIST17 | -0.20 ± 1.10 | 1.88 ± 1.81 | -3.08 | 3.02E-09 | 0.91 |
| 1,2-dibutyl-hydrazine | 12.49 | 1744-71-4 | NIST17 | -0.20 ± 0.93 | 1.87 ± 1.74 | -3.11 | 2.53E-11 | 0.91 |
| 1-octanol | 13.82 | 111-87-5 | S | -0.20 ± 1.31 | 1.87 ± 1.42 | -2.51 | 1.15E-07 | 0.91 |
| (Z)-2-penten-2-ol | 4.39 | 61923-54-4 | NIST17 / MSI | 0.20 ± 2.10 | -1.87 ± 1.87 | 2.10 | 5.51E-04 | 0.91 |
| 2,6-ditert-butyl-4-hydroxy-4-methylcyclohexa-2,5-dien-1-one | 25.51 | NA | NIST17 | -0.18 ± 0.97 | 1.71 ± 1.36 | -2.28 | 3.79E-10 | 0.83 |
| diphenyl ether | 23.68 | 101-84-8 | NIST17 / MSI | -0.18 ± 1.04 | 1.71 ± 1.19 | -1.83 | 1.86E-09 | 0.83 |
| 1-(4-aminophenyl)ethanone oxime | 7.20 | 38063-81-9 | NIST17 | -0.18 ± 1.14 | 1.70 ± 1.68 | -2.36 | 1.15E-07 | 0.82 |
| 2-isopropyl-5-methylpyrazine | 10.74 | 13925-05-8 | NIST17 | 0.18 ± 1.10 | -1.70 ± 1.78 | 1.55 | 7.04E-08 | 0.82 |
| benzaldehyde | 13.27 | 100-52-7 | S | -0.18 ± 1.70 | 1.70 ± 1.12 | -1.89 | 9.32E-05 | 0.82 |
| 3-octen-2-one | 10.90 | 1669-44-9 | S | -0.17 ± 1.37 | 1.64 ± 1.65 | -2.04 | 8.13E-06 | 0.80 |
| tri-sec-butyl ester orthoformic acid | 6.02 | 16754-48-6 | NIST17 | -0.17 ± 1.62 | 1.62 ± 1.36 | -2.02 | 1.12E-04 | 0.78 |
| 2-tert-butyl-3-(3,3-dimethylbutyl)oxirane | 25.09 | NA | MSI | 0.17 ± 1.49 | -1.61 ± 0.98 | 2.95 | 2.35E-05 | 0.78 |
| 1-octen-3-ol | 11.59 | 3391-86-4 | S | -0.17 ± 1.64 | 1.59 ± 1.00 | -1.86 | 1.23E-04 | 0.77 |
| 3-ethylcyclopentanone | 9.50 | 10264-55-8 | S | -0.17 ± 1.42 | 1.58 ± 0.95 | -2.13 | 1.28E-05 | 0.77 |
| methyl 2-phenylacetate | 18.34 | 101-41-7 | NIST17 / MSI | -0.17 ± 1.25 | 1.57 ± 2.41 | -4.35 | 1.94E-05 | 0.76 |
| 1-hexanol | 9.74 | 111-27-3 | S | -0.17 ± 1.28 | 1.55 ± 1.52 | -2.04 | 6.24E-06 | 0.75 |
| 2-ethenyl-6-methyl-pyrazine | 12.50 | 13925-09-2 | S | 0.16 ± 1.63 | -1.51 ± 0.79 | 3.55 | 2.13E-04 | 0.73 |
| 3-tert-butyl-2-pyrazolin-5-one | 18.30 | 29211-68-5 | S | -0.15 ± 1.32 | 1.43 ± 1.23 | -2.21 | 3.42E-05 | 0.69 |
| 2-acetyl-3,4,6-trimethylpyrazine | 18.50 | 125186-38-1 | NIST17 / MSI | 0.15 ± 1.31 | -1.40 ± 1.10 | 2.05 | 3.53E-05 | 0.68 |
| endo-borneol | 17.00 | 507-70-0 | NIST17 / MSI | -0.15 ± 1.26 | 1.40 ± 1.55 | -1.72 | 3.28E-05 | 0.68 |
| (E)-2,3-dimethyl-5-(1-propenyl) pyrazine | 15.20 | 80033-12-1 | NIST17 / MSI | 0.15 ± 1.52 | -1.37 ± 0.98 | 2.89 | 3.74E-04 | 0.66 |
| trans-β-ionone | 22.20 | 79-77-6 | NIST17 / MSI | -0.13 ± 1.30 | 1.26 ± 1.19 | -1.54 | 1.70E-04 | 0.61 |
| 2,6-dimethyl-2,6-octadiene | 17.90 | 2792-39-4 | NIST17 / MSI | -0.13 ± 1.36 | 1.24 ± 1.56 | -1.58 | 5.20E-04 | 0.60 |
aCompounds listed are those that met significance criteria of Adj. P < 0.001 and |log2 fold change| > 2.0.
bIdentification method
S = Experimental spectrum matched to authentic standard.
N17 = Experimental spectrum matched to NIST17 spectral library.
MSI = Experimental spectrum ion fragments matched to structure fragments in NIST MS Interpreter.
Fig 2VOCs with highest variable importance in classifying intact male and neutered male urine samples.
(a) Scores on first 2 latent variables from partial least squares-discriminant analysis shown for neutered male samples (n = 15) in gray circles and intact male samples (n = 141) in black triangles. Variance explained by each latent variable is shown in parentheses. (b) Variable influence on projection (VIP) scores on partial least squares latent variable 1 shown for 15 VOCs with statistically significant differential expression and highest VIP. Boxes on right indicate the log2 fold change in abundance of each VOC in intact male samples (n = 141) compared to a neutered male’s samples (n = 15).